Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × siltuximab × Other hematologic neoplasm × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 3 Lymphoid 3 Other hematologic neoplasm 1 Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Cytarabine 168 Cyclophosphamide 159 fludarabine 127 Azacitidine 103 venetoclax 99 fludarabine phosphate 96 Rituximab 76 Decitabine 65 Filgrastim 53 Etoposide 52 Specimen Handling 49 Lenalidomide 44 Biopsy 38 Daunorubicin 36 Methotrexate 35 Dexamethasone 34 ibrutinib 33 Mitoxantrone 33 Melphalan 33 Granulocyte Colony-Stimulating Factor 33 Vincristine 31 Dasatinib 31 Clofarabine 31 Bortezomib 31 Tacrolimus 30 Whole-Body Irradiation 29 Peripheral Blood Stem Cell Transplantation 29 Mycophenolic Acid 27 Injections 27 Idarubicin 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05697510 2023-04-06

SILTUXILAM

Nantes University Hospital

Phase 1 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡